SCHEMBL35212403

SCHEMBL35212403

N[C@H]1CCc2c1cccc2[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.43
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 4/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
GPR35 Q9HC97 1/20 0.40
MAPK1 P28482 1/20 0.40
LAP3 P28838 1/20 0.40
RECQL P46063 1/20 0.39
MCL1 Q07820 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
TSHR P16473 3/20 0.38
LMNA P02545 1/20 0.38
KDM4E B2RXH2 2/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CUL4A Q13619 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871363 1.00 ACHE (0.43) ACHETDP1MAPTKMT2AALDH1A1
SCHEMBL5333511 0.90 MAPT (0.41) TDP1MAPTKMT2AALDH1A1MEN1
SCHEMBL29325249 0.89 MAPT (0.43) TDP1MAPTKMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL30002911 0.88 MAPT (0.43) ACHETDP1MAPTKMT2AALDH1A1
SCHEMBL3025170 0.80 TDP1 (0.41) TDP1MAPTKMT2AALDH1A1MEN1
SCHEMBL18339431 0.80 GPR35 (0.44) TDP1MAPTKMT2AALDH1A1MEN1
SCHEMBL18658368 0.80 TDP1 (0.44) ACHETDP1MAPTKMT2AALDH1A1
SCHEMBL35212145 0.80 GPR35 (0.44) TDP1MAPTKMT2AALDH1A1MEN1
SCHEMBL35212357 0.80 GPR35 (0.44) TDP1MAPTKMT2AALDH1A1MEN1
SCHEMBL1573408 0.80 GPR35 (0.44) TDP1MAPTKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125359-A1 HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS FUJIAN HAIXI PHARMACEUTICALS CO LTD (CN) 2026-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125359-A1 HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS ERBB2, ERBB3, ARRB1 ACHE 4588/4885TDP1 3612/4885MAPT 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.